TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI,Jan. 21,2025-- TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311,the first anticoagulant oral dissolving film (ODF). This trial was conducte